Topics in Drug Testing from Quest Diagnostics

Topics in Drug Testing from Quest Diagnostics header image 1

Drug Misuse in America

quest-ep7-tweet-drugmisuse.png

Welcome to the Quest Diagnostics “topics in drug testing” podcast. Today’s episode is with Quest Diagnostics senior medical advisor, Drug Monitoring and Toxicology, Dr Jeff Gudin, and Justin Niles, lead medical informatics analyst for Quest Diagnostics Health Trends™. 

 

The podcast will cover:

  • Key findings from the Quest Diagnostics Health Trends report, Drug Misuse in America 2019
  • Summary of analysis of more than 4.4 million de-identified drug monitoring tests performed by Quest Diagnostics from 2011 through 2018
  • Findings of a Harris Poll survey of 500 primary care physicians, as part of Health Trends report analysis
  • Highlights of the evolving drug misuse crisis in America, including Drug mixing and the overdose death connection
  • Key challenges facing physicians today, with regards to identifying drug misuse, and treating patients with chronic pain 
  • The role and importance of drug monitoring and incorporating it into medical practice

You may download a PDF version of this presentation here>>

 

To listen to other podcasts in our series or learn more about Quest Diagnostics' comprehensive drug testing offering, please visit QuestDrugMonitoring.com. There you will find our Drug Monitoring Test Directory, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics we are committed to providing you results and insight to support your clinical decisions.

Kratom: Identifying “a drug of concern”

quest-ep6-tweet-kratom.png

Welcome to the Quest Diagnostics “topics in drug testing” podcast. Today’s episode is with Jack Kain, PharmD, Quest Diagnostics medical science liaison, and Jeff Gudin, MD, senior medical advisor, Quest Diagnostics drug monitoring. Drs Kain and Gudin will be discussing “testing for kratom.” The podcast will cover:

  • What is kratom?

    • o What is the chemical make-up?
  • Kratom toxicity and side effects
  • Testing for kratom
    • Why testing is important?
    • How to test for kratom
    • What testing will tell you

 

You may download a PDF version of this presentation here>>

 

To listen to other podcasts in our series or learn more about Quest Diagnostics' comprehensive drug testing offering, please visit QuestDrugMonitoring.com. There you will find our Drug Monitoring Test Directory, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics we are committed to providing you results and insight to support your clinical decisions.

Why and when to use oral fluid testing

quest-ep5-twitter.png

Welcome to the Quest Diagnostics “topics in drug testing” podcast. Today’s episode is with Les Edinboro, PhD, Quest Diagnostics executive science director, toxicology and drug monitoring, and Jeff Gudin, MD, senior medical advisor Quest Diagnostics drug monitoring. Drs Edinboro and Gudin will be discussing “why and when to use oral fluid testing.”

The podcast will cover:

  • What is oral fluid testing?
  • Compare oral fluid testing to other methods of testing
  • What are the benefits of oral fluid testing?
  • What are some of the drugs oral fluid testing can identify?
    • How are the drugs identified?
    • How is the sample collected?
  • Discuss some of the collection issues

You may download a PDF version of this presentation here >>
Download the oral fluid specimen collection instructions PDF here >>
Download the oral fluid testing brochure PDF here >>

To listen to other podcasts in our series or learn more about Quest Diagnostics comprehensive drug testing offering, please visit QuestDrugMonitoring.com. There you will find our Drug Monitoring Test Directory, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics we are committed to providing you results and insight to support your clinical decisions.

Dangerous drug combinations

quest-ep4-twitter.png

Welcome to the Quest Diagnostics “topics in drug testing” podcast. Today’s episode is with Quest Diagnostics Senior Medical Advisor Dr Jeff Gudin and Medical Science Liaison Dr Jack Kain. Drs Gudin and Kain will be discussing “dangerous drug combinations.”

The podcast will cover:

  • What are dangerous drug combinations
  • What practitioners and the public need to know about them
  • How the drug combinations can work together to lead to side effects
    • Certain combinations predispose people to a greater risk of overdose and death
    • Can affect drug levels, creating a pharmacokinetic drug–drug interaction
    • May result in excessive sedation
  • How drug testing can help
    • A tool to identify dangerous drug combinations
    • Identifies metabolites unique to a substance

You may download the PDF version of this presentation here>>

To learn more, please visit QuestDrugMonitoring.com for information on our Drug Monitoring Test Directory and offerings, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics, we are committed to providing you results and insights to support your clinical decisions.

Screening for alcohol use in pain management and primary care: it’s about time

quest-ep3-tweet.png

Welcome to the Quest Diagnostics “Topics in drug testing” podcast. Today’s episode is with Quest Diagnostics Senior Medical Advisor Dr Jeff Gudin and Medical Science Liaison Dr Jack Kain. Drs Gudin and Kain will be discussing “Screening for alcohol use in pain management and primary care.”

The podcast will cover the importance of alcohol testing in order to:

  • Understand drug and alcohol misuse and abuse

    • Share prevalence rates of alcohol use and misuse, and alcohol use disorders
    • Provide information on alcohol use, and concomitant use with opioids and benzodiazepines
  • Screening guidelines
    • Tools and types of tests
  • Testing for alcohol
    • Breathalyzer
    • Advances in testing
    • Biomarkers
    • Other considerations
    • Quest Diagnostics approach

You may download the PDF version of this presentation here>>

To learn more, please visit QuestDrugMonitoring.com for information on our Drug Monitoring Test Directory and offerings, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics, we are committed to providing you results and insights to support your clinical decisions.

Patients with substance use disorders in medication-assisted treatment (MAT)

ep2-quest-tweet.png

Welcome to the Quest Diagnostics “topics in drug testing” podcast. Today’s episode is with Quest Diagnostics Senior Medical Advisor, Dr Jeff Gudin, and Medical Science Liaison, Dr Jack Kain. They will be discussing drug testing for patients with substance use disorders in medication-assisted treatment (MAT).

In today’s episode, some of the points that will be covered include:

  • What is medication-assisted treatment?
  • What are the goals of the treatment program?
  • The medications used in the treatment program 
  • Drug testing during MAT
    • Purpose of drug testing
    • Types of drug testing
      • Specimen collection
      • Specimen validity
    • Test confirmation

You may download the PDF version of this presentation here >

To learn more, please visit QuestDrugMonitoring.com for information on our Drug Monitoring Test Directory and offerings, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics, we are committed to providing you results and insights to support your clinical decisions.

Drug testing your patients for marijuana

1200x675_quest-ep1-thc.png

Welcome to the Quest Diagnostics “topics in drug testing” podcast. Today’s episode is with Quest Diagnostics Senior Medical Advisor, Dr Jeff Gudin, and Medical Science Liaison, Dr Jack Kain. They will be discussing drug testing your patients for marijuana.

Today, we’ll be talking about marijuana and marijuana-based products in order to:

  • Understand drug testing for marijuana, and why it’s important
  • Give some general recommendations for therapeutic drug monitoring for marijuana in patients with chronic pain using controlled substances
    • For example, at a minimum such patients should be tested before opioid therapy begins, again within 1 to 3 months, and randomly over the next 12 months, and more frequently if there are unexpected results, or there are complaints or behavior changes in the patient

 You may download the PDF version of this presentation here >

To learn more, please visit QuestDrugMonitoring.com for information on our Drug Monitoring Test Directory and offerings, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics, we are committed to providing you results and insights to support your clinical decisions.

Play this podcast on Podbean App